Market Overview

UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Varian Medical Systems

Related VAR
Varian Showcases Halcyon System at DEGRO Meet, Stock Up
Benzinga's Option Alert Recap From April 28

In a report published Friday, Jefferies & Company reiterated its Buy rating on Varian Medical Systems (NYSE: VAR), and raised its price target from $65.00 to $68.00.

Jefferies noted, “VAR posted a strong F4Q with beats in revenues, EPS, and orders. Initial F13 guidance calls for 8-9% top-line growth. The strong surge in orders and higher outlook should ease persistent concerns of pressures from potential CMS reimbursement cuts, pricing, and competition.”

Varian Medical Systems closed on Thursday at $58.10.

Latest Ratings for VAR

May 2017Goldman SachsInitiates Coverage OnNeutral
May 2017BTIG ResearchUpgradesNeutralBuy
Feb 2017Aegis CapitalInitiates Coverage OnHold

View More Analyst Ratings for VAR
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings


Related Articles (VAR)

View Comments and Join the Discussion!